There were 25% more new cancers in elderly people 70-82 who were given 40 mg of pravastatin (Pravachol) per day to lower cholesterol compared to those given a placebo according to the PROSPER trial.

“In 2015, excess weight affected 2.2 billion children and adults worldwide, or 30% of all people,” according to a new report on overweight and obesity in 195 countries in the last 25 years.

“This includes nearly 108 million children and more than 600 million adults with BMI exceeding 30, the threshold for obesity, according to the study.”

“Of the 4 million deaths attributed to excess body weight in 2015, nearly 40% occurred among people whose body mass index (BMI) fell below the threshold considered ‘obese’ according to a new report on overweight and obesity in 195 countries in the last 25 years.

In 2015, a total of 108 million children and 604 million adults were obese worldwide according to a new report on overweight and obesity in 195 countries in the last 25 years.

“Since 1980, the prevalence of obesity has doubled in more than 70 countries and has continuously increased in most other countries” according to a new report on overweight and obesity in 195 countries in the last 25 years.

“More than two thirds of deaths related to high BMI were due to cardiovascular disease” according to a new report on overweight and obesity in 195 countries in the last 25 years.

People 75-years and older without cardiovascular disease who took the statin, pravastatin (Pravachol, 40 mg/day), to lower cholesterol were 34% more likely to have died during the 8 year study than people of the same age not taking a statin although the difference did not quite reach statistical significance.

(There was a 7% chance that the difference between the two groups was due to random chance, but this is close enough for me.)

There were 92 deaths in the pravastatin group versus 65 deaths in the non-statin group.

At the very least this means that pravastatin (Pravachol) provides no benefit to people of this age, and at worst, it means that pravastatin (Pravachol) increases the risk of death considerably.

People 65- to 74-years-old without heart disease who took the statin, pravastatin (Pravachol, 40 mg/day), to lower cholesterol were 8% more likely to have died during the 8 year study than people of the same age not taking a statin although the difference was not statistically significant.

There were 141 deaths in the pravastatin group versus 130 deaths in the non-statin group.

At the very least this means that pravastatin (Pravachol) provides no benefit to people of this age, and at worst, it means that pravastatin (Pravachol) increases the risk of death.

People whose maximum body mass index (BMI) over 16 years was in the overweight range (BMI of 25-29.9) were 6% more likely to die than people whose maximum BMI was in the normal range (BMI of 18.5–24.9) during an average follow-up of 12 years according to data from the Nurses’ Health Study I and II and Health Professionals Follow-Up Study which included 225,072 men and women.

However, when they only looked a person’s weight at the beginning of the study, being overweight (BMI of 25-29.9) was associated with a 4% lower risk of death during the 12 year follow-up.

However, when they included maximum BMI, they found an increased risk of death.

People whose maximum body mass index (BMI) over 16 years was in the obese I range (BMI of 30-34.99) were 24% more likely to die than people whose maximum BMI was in the normal range (BMI of 18.5–24.9) during an average follow-up of 12 years according to data from the Nurses’ Health Study I and II and Health Professionals Follow-Up Study which included 225,072 men and women.

People whose maximum body mass index (BMI) over 16 years was in the obese II range (BMI of 35 or more) were 73% more likely to die than people whose maximum BMI was in the normal range (BMI of 18.5–24.9) during an average follow-up of 12 years according to data from the Nurses’ Health Study I and II and Health Professionals Follow-Up Study which included 225,072 men and women.

Among people given phentermine to lose weight, 84% (81 out of 97) responded, while 16% (16 out of 97) did not according to a new study.

People without diabetes given 30 or 37 mg of phentermine lost an average of 23 lbs in 6 months according to a new study.

Systolic blood pressure dropped by an average of 6 mm Hg.

Phentermine causes an average weight loss of 16 lbs in people with HbA1c less than 6% according to a new study.

(HbA1c is the 3 month average blood sugar levels.)

Phentermine causes an average weight loss of 7 lbs in people with HbA1c of 6% to 6.5% according to a new study.

(HbA1c is the 3 month average blood sugar levels.)

Phentermine causes an average weight loss of 9 lbs in people with HbA1c of more than 6.5% according to a new study.

(HbA1c is the 3 month average blood sugar levels.)

The one-fifth of people consuming the most whole grains (34 grams per day) were 17% less likely to die during an average follow-up of 14 years compared to the one-fifth of people consuming the least (4 grams per day) according to a study of 367,442 people from the prospective NIH-AARP Diet and Health Study.

People consuming 3 or more servings of fruits and vegetables per day had a 27% lower risk of having a stroke and a 42% lower risk of dying from a stroke during an average follow-up of 19 years compared to people consuming less than one serving of fruit and vegetables per day.

This according to a study of 9608 adults aged 25- 74-years-old participating in the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study and free of cardiovascular disease at the time of their baseline examination between 1971 and 1975.

People consuming 3 or more servings of fruits and vegetables per day had a 27% lower risk of dying from cardiovascular disease (CVD) during an average follow-up of 19 years compared to people consuming less than one serving of fruit and vegetables per day.

This according to a study of 9608 adults aged 25- 74-years-old participating in the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study and free of cardiovascular disease at the time of their baseline examination between 1971 and 1975.

People consuming 3 or more servings of fruits and vegetables per day had a 15% lower risk of dying during an average follow-up of 19 years compared to people consuming less than one serving of fruit and vegetables per day.

This according to a study of 9608 adults aged 25- 74-years-old participating in the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study and free of cardiovascular disease at the time of their baseline examination between 1971 and 1975.

The most popular statins increase the risk of Parkinson’s Disease by 58% according to new study.

These are the lipophilic statins, meaning that they dissolve in fats, which include atorvastatin (Lipitor), fluvastatin (Lescol), lovastatin (Mevacor), pitavastatin (Livalo), simvastatin (Zocor).

People taking both a statin and a nonstatin to lower cholesterol levels had a 95% increased risk of Parkinson’s compared to people taking neither according to a new study.

Nonstatin cholesterol-lowering drugs included fenofibrate (Trilipix, Tricor, Triglide, Antara, Lipofen, Fibricor, Lofibra, and Fenoglide), ezetimibe (Zetia), and niacin.

This study found that the most popular statins increase the risk of Parkinson’s Disease by 58%.

These are the lipophilic statins, meaning that they dissolve in fats, which include atorvastatin (Lipitor), fluvastatin (Lescol), lovastatin (Mevacor), pitavastatin (Livalo), simvastatin (Zocor).

Ex-smokers who exercise were 30% less likely to have died over some number of years compared to ex-smokers who do not exercise according to an analysis of self-reported exercise and smoking in 106,341 adults in the Health Survey for England and the Scottish Health Survey.

The risk of dying from cardiovascular disease was 29% lower in ex-smokers who exercised versus those who do not.

The risk of dying from cancer was 34% lower in ex-smokers who exercised versus those who do not.

Similar results were found in smokers who exercised versus smokers who do not.

The risk of dying over some number of years was 31% lower in smokers who exercise versus smokers who do not.

Among people who had never smoked, people who drank 3.1 to 5 cups of coffee per day had a 42% lower risk of suicide over some number of years compared to people who were not coffee drinkers according to an analysis of data from 74,890 women in the Nurses’ Health Study, 93,054 women in the Nurses’ Health Study II, and 40,557 men in the Health Professionals Follow-up Study.

People who consumed more than 5 cups of coffee per day had a 46% lower risk of suicide compared to non-drinkers.

Among people who had never smoked, people who drank 3.1 to 5 cups of coffee per day had a 35% lower risk of dying from diabetes over some number of years compared to people who were not coffee drinkers according to an analysis of data from 74,890 women in the Nurses’ Health Study, 93,054 women in the Nurses’ Health Study II, and 40,557 men in the Health Professionals Follow-up Study.

People who consumed 1.1 to 3.0 cups of coffee per day had a 41% lower risk of dying from diabetes compared to non-drinkers.

People who consumed more than 5 cups of coffee per day had a 43% lower risk of dying from diabetes compared to non-drinkers.

Among people who had never smoked, people who drank 3.1 to 5 cups of coffee per day had a 31% lower risk of dying from a neurological disease (Alzheimer’s or Parkinson’s) over some number of years compared to people who were not coffee drinkers according to an analysis of data from 74,890 women in the Nurses’ Health Study, 93,054 women in the Nurses’ Health Study II, and 40,557 men in the Health Professionals Follow-up Study.

People who consumed more than 5 cups of coffee per day had a 40% lower risk of dying from a neurological disease (Alzheimer’s or Parkinson’s) compared to non-drinkers.

Among people who had never smoked, people who drank one cup of coffee per day or less had a 6% lower risk of dying over some number of years compared to people who were not coffee drinkers according to an analysis of data from 74,890 women in the Nurses’ Health Study, 93,054 women in the Nurses’ Health Study II, and 40,557 men in the Health Professionals Follow-up Study.

Among people who had never smoked, people who drank 1.1 to 3 cups of coffee per day had a 8% lower risk of dying over some number of years compared to people who were not coffee drinkers according to an analysis of data from 74,890 women in the Nurses’ Health Study, 93,054 women in the Nurses’ Health Study II, and 40,557 men in the Health Professionals Follow-up Study.

Among people who had never smoked, people who drank 3.1 to 5 cups of coffee per day had a 15% lower risk of dying over some number of years compared to people who were not coffee drinkers according to an analysis of data from 74,890 women in the Nurses’ Health Study, 93,054 women in the Nurses’ Health Study II, and 40,557 men in the Health Professionals Follow-up Study.

Among people who had never smoked, people who drank more than 5 cups of coffee per day had a 12% lower risk of dying over some number of years compared to people who were not coffee drinkers according to an analysis of data from 74,890 women in the Nurses’ Health Study, 93,054 women in the Nurses’ Health Study II, and 40,557 men in the Health Professionals Follow-up Study.

Each increase in consumption of one (1) cup of coffee per day was associated with a 6% lower risk of death in non-smokers over some number of years according to an analysis of 31 studies including a total of 1,610,543 people.

“In conclusion, coffee consumption is associated with decreased risk of mortality from all-cause, [ cardiovascular disease ], and cancer,” the authors of the paper concluded.

People drinking up to four (4) cups of coffee per day were 14% less likely to die over some number of years according to an analysis of 31 studies including a total of 1,610,543 people.

“In conclusion, coffee consumption is associated with decreased risk of mortality from all-cause, [ cardiovascular disease ], and cancer,” the authors of the paper concluded.

Increasing dietary magnesium intake by 100 mg per day is associated with a 10% reduction in the risk of death during a 4-30 year follow-up according to an analysis of 40 studies totaling more than one million people.

Increasing dietary magnesium intake by 100 mg per day is associated with a 22% reduction in the risk of congestive heart failure according to an analysis of 40 studies totaling more than one million people.

Increasing dietary magnesium intake by 100 mg per day is associated with a 7% reduction in the risk of stroke according to an analysis of 40 studies totaling more than one million people.

Increasing dietary magnesium intake by 100 mg per day is associated with a 19% reduction in the risk of type 2 diabetes according to an analysis of 40 studies totaling more than one million people.

“Among the [twelve (12)] Western European countries studied, the large increase in statin utilisation between 2000 and 2012 was not associated with [coronary heart disease] mortality, nor with its rate of change over the years,” notes a recent study.

Statin use is associated with a 10-13% increased risk of cataracts according to a new paper.

Men and women who replaced 3% of their animal protein intake (from red meat, fish, chicken, dairy, eggs) with plant protein were 10% less likely to die during a 26-32 year follow-up according to data from the Nurses’ Health Study and the Health Professionals Follow-up Study.

“Major food contributors to plant protein included bread, cereals, pasta, nuts, beans, and legumes,” the paper notes.

Men and women who replaced 3% of their protein intake from processed red meat with plant protein were 34% less likely to die during a 26-32 year follow-up according to data from the Nurses’ Health Study and the Health Professionals Follow-up Study.

To say this the other way, replacing 3% of plant protein intake with processed red meat was associated with a 52% greater risk of death during follow-up.